Other languages Cosmo Pharmaceuticals N.V.

Equities

Market Closed - Swiss Exchange Other stock markets 16:31:30 26/04/2024 BST			5-day change	1st Jan Change
71.6 ^CHF	-0.69%		+0.28%	+40.67%

04-26	Cosmo Pharmaceuticals N.V. Announces Executive Changes at the Upcoming Annual General Meeting on 24 May 2024	CI
04-25	Cosmo Pharmaceuticals Names New CEO, Chairman	MT

Cosmo Pharmaceuticals N.V. Announces Executive Changes at the Upcoming Annual General Meeting on 24 May 2024	04-26
Cosmo Pharmaceuticals Names New CEO, Chairman	04-25
Changements à la tête de Cosmo	04-25
Cosmo ernennt Giovanni Di Napoli zum neuen CEO - Della Chà wird VR-Präsident	04-25
Cosmo treibt mit dem Partner Medtronic endoskopische Versorgung voran	04-12
Cosmo Pharmaceuticals N.V. Proposes Dividend Payment for 2024	03-20
Cosmo Pharmaceuticals N.V. Provides Earnings Guidance for the Year 2024 and Revenue Guidance for 2025	03-20
Cosmo voit ses revenus reculer en 2023	03-20
Cosmo stellt trotz Gewinnrückgang verdoppelte Dividende in Aussicht	03-20
Cosmo Pharmaceuticals' FY23 Profit, Revenue Drops	03-20
Cosmo Pharmaceuticals N.V. Reports Earnings Results for the Full Year Ended December 31, 2023	03-19
Bourse Zurich: le SMI finit sous la barre des 11'600 points	03-19
Cosmo: feu vert pour la commercialisation du Winlevi aux antipodes	03-19
Cosmo erhält Zulassung für Winlevi in Australien	03-19
Cosmo Pharmaceuticals Partner Gets Regulatory Approval for Acne Treatment in Australia	03-19
Bourse Zurich: en vert à l'entame d'une "semaine banques centrales"	12-11
Les actions en mouvement : Solvay s'effondre dans le cadre de sa scission	12-11
Bourse Zurich: prudence en entame de semaine dominée par les banques centrales	12-11
Cosmo étend son partenariat avec Medtronic	12-11
Cosmo und Medtronic treiben KI-Behandlung voran - Aktie legt zweistellig zu	12-11

No results for this search